Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

Videos

Out-of-Pocket Costs of Oral Hormonal Therapies High for Patients With Prostate Cancer
Videos
Out-of-Pocket Costs of Oral Hormonal Therapies High for Patients With Prostate Cancer
02/18/2021
02/18/2021
Journal of Clinical Pathways
Adoption of Avelumab for First-Line Maintenance Therapy of Urothelial Cancer in US
Videos
Adoption of Avelumab for First-Line Maintenance Therapy of Urothelial Cancer in US
02/18/2021
02/18/2021
Journal of Clinical Pathways
PTEN Loss of Function Associated With Worse Survival in Metastatic CRPC
Videos
PTEN Loss of Function Associated With Worse Survival in Metastatic CRPC
02/18/2021
02/18/2021
Journal of Clinical Pathways
Pembrolizumab Unlikely Cost-Effective for BCG-Unresponsive Bladder Cancer in US
Videos
Pembrolizumab Unlikely Cost-Effective for BCG-Unresponsive Bladder Cancer in US
02/17/2021
02/17/2021
Journal of Clinical Pathways
Symptom Burden, Functional Status of Hospitalized Patients With Genitourinary Cancers vs Other Cancers
Videos
Symptom Burden, Functional Status of Hospitalized Patients With Genitourinary Cancers vs Other Cancers
02/17/2021
02/17/2021
Journal of Clinical Pathways
Apalutamide Plus ADT Improves Long-Term Survival in Metastatic Castration-Sensitive Prostate Cancer
Videos
Apalutamide Plus ADT Improves Long-Term Survival in Metastatic Castration-Sensitive Prostate Cancer
02/14/2021
02/14/2021
Journal of Clinical Pathways
Apalutamide Added to Abiraterone Acetate Plus Prednisone Improves Outcomes in Metastatic CRPC
Videos
Apalutamide Added to Abiraterone Acetate Plus Prednisone Improves Outcomes in Metastatic CRPC
02/12/2021
02/12/2021
Journal of Clinical Pathways
HRQoL Low Among Young Adult Colorectal Cancer Survivors
Videos
HRQoL Low Among Young Adult Colorectal Cancer Survivors
02/04/2021
Kimberly Miller, PhD, MPH, discusses results from a study exploring HRQoL in colorectal cancer survivors who were diagnosed before age 50.
Kimberly Miller, PhD, MPH, discusses results from a study exploring HRQoL in colorectal cancer survivors who were diagnosed before age 50.
Kimberly Miller, PhD, MPH,...
02/04/2021
Journal of Clinical Pathways
JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Popular Articles

Conference Coverage
American Society of Clinical Oncology (ASCO) 2016 Annual Meeting
05/31/2016
Its once again time for the American Society of Clinical Oncology (ASCO) Annual Meeting (June 3-7, 2016; Chicago, IL), which will bring together more than 30,000 oncology professionals from around the world to...
Its once again time for the American Society of Clinical Oncology (ASCO) Annual Meeting (June 3-7, 2016; Chicago, IL), which will bring together more than 30,000 oncology professionals from around the world to...
Its...
05/31/2016
Journal of Clinical Pathways
Editor's Page
For Buy-In of the Clinical Pathways Concept, Transparency Is Key
05/06/2016
Winston Wong, PharmD, Editor-in-Chief
Essential to the success of clinical pathways is transparency of the development process. This includes transparency regarding the clinical evidence reviewed, the economic evaluations made, and the process by which...
Essential to the success of clinical pathways is transparency of the development process. This includes transparency regarding the clinical evidence reviewed, the economic evaluations made, and the process by which...
...
05/06/2016
Journal of Clinical Pathways
Pharma Insights
When Medication Price Deflates Perception of Therapeutic Effect
04/11/2016
Larry Blandford, PharmD—Column Editor
Stephen C Carter
Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...
Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...
...
04/11/2016
Journal of Clinical Pathways
Research in Review
Report Outlines the Path to Improving Biomarker Tests for Targeted Therapies
03/21/2016
JCP Editors
Biomarker tests are not being adequately used in clinical practice due to a lack of common evidentiary standards for regulatory, reimbursement, and clinical decisions regarding their use, according to a report by the...
Biomarker tests are not being adequately used in clinical practice due to a lack of common evidentiary standards for regulatory, reimbursement, and clinical decisions regarding their use, according to a report by the...
...
03/21/2016
Journal of Clinical Pathways
Research in Review
Costs for High-Risk Patients With ALL Increasing
02/25/2016
JCP Editors
Costs for high-risk pediatric and adolescent patients with acute lymphoblastic leukemia (ALL) may be higher than standard-risk patients with the disease, according to a recent study. While data regarding health care...
Costs for high-risk pediatric and adolescent patients with acute lymphoblastic leukemia (ALL) may be higher than standard-risk patients with the disease, according to a recent study. While data regarding health care...
Costs...
02/25/2016
Journal of Clinical Pathways

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement